Sharma Suman B, Garg Seema
Department of Biochemistry, University College of Medical Sciences & GTB Hospital, University of Delhi, Delhi 110095, India.
Indian J Biochem Biophys. 2012 Apr;49(2):77-85.
Pathogenesis of coronary artery disease (CAD) is multi-factorial and many risk factors are associated with development of CAD. LDL-C has been an important target for therapeutic interventions and has been extensively studied. But, various studies have indicated that estimation of LDL-C is not enough to assess the risk. Moreover, LDL particles vary in their content, density and size which have different physico-chemical properties. In this paper, the role of small dense (sd) LDL in risk assessment for CAD and its response to different therapeutic modalities available have been reviewed.
冠状动脉疾病(CAD)的发病机制是多因素的,许多风险因素与CAD的发展相关。低密度脂蛋白胆固醇(LDL-C)一直是治疗干预的重要靶点,并已得到广泛研究。但是,各种研究表明,仅评估LDL-C不足以评估风险。此外,LDL颗粒在其含量、密度和大小方面存在差异,具有不同的物理化学性质。本文综述了小而密(sd)LDL在CAD风险评估中的作用及其对现有不同治疗方式的反应。